Autopsy report · NCT00315614
Islet Cell Transplantation Alone and CD34+ Donor Bone Marrow Cell Infusion in Type 1 Diabetes Mellitus
Cause of deathOther
“We did not achieve a tolerogenic profile. Subjects withdrew from protocol and enrolled in other islet transplant trials.”
Life of this trial
- Registered 5 years 4 months after it had already started.
- Ran for about 10 years before it stopped.
- 3 participants enrolled.
- Results were posted on the registry 3 years 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- University of Miami
- Sponsor type
- University, hospital or other
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- Islet Transplantation and Bone Marrow
- Participants
- 3
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.